738 related articles for article (PubMed ID: 17130267)
21. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study.
Alber HF; Frick M; Suessenbacher A; Doerler J; Schirmer M; Stocker EM; Dichtl W; Pachinger O; Weidinger F
Am Heart J; 2006 Jan; 151(1):139. PubMed ID: 16368305
[TBL] [Abstract][Full Text] [Related]
22. The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia.
Takebayashi K; Matsumoto S; Wakabayashi S; Inukai Y; Matsutomo R; Aso Y; Inukai T
Metabolism; 2005 Sep; 54(9):1225-9. PubMed ID: 16125534
[TBL] [Abstract][Full Text] [Related]
23. Acute effect of simvastatin on inflammation and oxidative stress in chronic kidney disease.
Dummer CD; Thome' FS; Zingano B; Lindoso A; Veronese FV
J Nephrol; 2008; 21(6):900-8. PubMed ID: 19034875
[TBL] [Abstract][Full Text] [Related]
24. Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects.
Bruni F; Pasqui AL; Pastorelli M; Bova G; Di Renzo M; Cercigani M; Leo A; Auteri A; Puccetti L
Int J Cardiol; 2004 Jun; 95(2-3):269-74. PubMed ID: 15193831
[TBL] [Abstract][Full Text] [Related]
25. Atorvastatin treatment in the short term: does it induce renoprotection or vasculoprotection in renal transplantation?
Navarro-Muñoz M; Bonet J; Bayés B; Lauzurica R; Blanco S; Romero R
Transplant Proc; 2007 Sep; 39(7):2259-63. PubMed ID: 17889157
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of atorvastatin after LDL-cholesterol-based dose selection in high risk dyslipidaemic patients: results of the target dose study.
Ducobu J; Claeys M; Commers K; Van Mieghem W; Nachtergaele H; Vandenbroucke M; Deforce J
Curr Med Res Opin; 2007 Aug; 23(8):1821-7. PubMed ID: 17609019
[TBL] [Abstract][Full Text] [Related]
27. Synergistic effect of angiotensin-converting enzyme (ACE) and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibition on inflammatory markers in atherosclerotic rabbits.
Oubiña MP; de las Heras N; Cediel E; Sanz-Rosa D; Aragoncillo P; Díaz C; Hernández G; Lahera V; Cachofeiro V
Clin Sci (Lond); 2003 Dec; 105(6):655-62. PubMed ID: 12848617
[TBL] [Abstract][Full Text] [Related]
28. Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.
Dornbrook-Lavender KA; Joy MS; Denu-Ciocca CJ; Chin H; Hogan SL; Pieper JA
Pharmacotherapy; 2005 Mar; 25(3):335-44. PubMed ID: 15843280
[TBL] [Abstract][Full Text] [Related]
29. Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with type 2 diabetes mellitus.
Amudha K; Choy AM; Mustafa MR; Lang CC
Cardiovasc Ther; 2008; 26(4):253-61. PubMed ID: 19035876
[TBL] [Abstract][Full Text] [Related]
30. Safety and effects on the lipid and C-reactive protein plasma concentration of the association of ezetimibe plus atorvastatin in renal transplant patients treated by cyclosporine-A: a pilot study.
Panichi V; Manca-Rizza G; Paoletti S; Taccola D; Consani C; Sbragia G; Mantuano E; Marchetti V; Carpi A; Barsotti G
Biomed Pharmacother; 2006 Jun; 60(5):249-52. PubMed ID: 16740374
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
[TBL] [Abstract][Full Text] [Related]
32. An increase of C-reactive protein is associated with enhanced activation of endogenous fibrinolysis at baseline but an impaired endothelial fibrinolytic response after venous occlusion.
Speidl WS; Zeiner A; Nikfardjam M; Geppert A; Jordanova N; Niessner A; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
J Am Coll Cardiol; 2005 Jan; 45(1):30-4. PubMed ID: 15629369
[TBL] [Abstract][Full Text] [Related]
33. Effect of low doses of atorvastatin on the urinary peptide profile of kidney transplant patients.
Pérez V; Navarro-Muñoz M; Bayés B; Lauzurica R; Pastor MC; Troya M; Bonet J; Ibernón M; Navarro M; Serra A; Núñez A; Romero R
Transplant Proc; 2009; 41(6):2111-4. PubMed ID: 19715847
[TBL] [Abstract][Full Text] [Related]
34. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients.
Joy MS; Dornbrook-Lavender KA; Chin H; Hogan SL; Denu-Ciocca C
Ann Pharmacother; 2008 Jan; 42(1):9-15. PubMed ID: 18000162
[TBL] [Abstract][Full Text] [Related]
35. Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis.
Van Doornum S; McColl G; Wicks IP
Ann Rheum Dis; 2004 Dec; 63(12):1571-5. PubMed ID: 15547080
[TBL] [Abstract][Full Text] [Related]
36. Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration.
Blanco-Colio LM; Martín-Ventura JL; de Teresa E; Farsang C; Gaw A; Gensini G; Leiter LA; Langer A; Martineau P; Egido J;
Am Heart J; 2007 May; 153(5):881-8. PubMed ID: 17452168
[TBL] [Abstract][Full Text] [Related]
37. A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.
Bianchi S; Bigazzi R; Caiazza A; Campese VM
Am J Kidney Dis; 2003 Mar; 41(3):565-70. PubMed ID: 12612979
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
Harikrishnan S; Rajeev E; Tharakan JA; Titus T; Ajit Kumar VK; Sivasankaran S; Krishnamoorthy KM; Nair K
Indian Heart J; 2008; 60(3):215-22. PubMed ID: 19240310
[TBL] [Abstract][Full Text] [Related]
39. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia.
Milionis HJ; Kakafika AI; Tsouli SG; Athyros VG; Bairaktari ET; Seferiadis KI; Elisaf MS
Am Heart J; 2004 Oct; 148(4):635-40. PubMed ID: 15459594
[TBL] [Abstract][Full Text] [Related]
40. Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance.
Fogari R; Derosa G; Lazzari P; Zoppi A; Fogari E; Rinaldi A; Mugellini A
Am J Hypertens; 2004 Sep; 17(9):823-7. PubMed ID: 15363826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
